|Day Low/High||0.49 / 0.53|
|52 Wk Low/High||0.26 / 1.57|
I continue to believe that biotech and biopharma stocks will outperform in 2018.
New drugs give small-cap companies opportunity to expand markets and revenues.
The bears are trying it out on the Bank of England news today, but they may get squeezed.
Market players are unlikely to retreat until we push through 5,000.